Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971
What this trial is testing
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Who this might be right for
Chronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase
H. Lee Moffitt Cancer Center and Research Institute 24